Combining SBRT to Standard Therapy for Metastatic Prostate Cancer Significantly Improves Outcome

Combining stereotactic body radiation therapy (SBRT), such as CyberKnife with standard systemic therapy yielded significant increases in the rates of biochemical response and progression-free survival (PFS) in patients with oligometastatic castrate-resistant prostate...